- Home
- IZM vs GDTC Comparison
IZM vs GDTC Comparison
Compare IZM & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- GDTC
- Stock Information
- Founded
- IZM 2011
- GDTC 2018
- Country
- IZM China
- GDTC Singapore
- Employees
- IZM N/A
- GDTC N/A
- Industry
- IZM Consumer Electronics/Video Chains
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- IZM Consumer Discretionary
- GDTC Health Care
- Exchange
- IZM Nasdaq
- GDTC Nasdaq
- Market Cap
- IZM 28.7M
- GDTC 28.0M
- IPO Year
- IZM 2023
- GDTC 2023
- Fundamental
- Price
- IZM $2.59
- GDTC $2.14
- Analyst Decision
- IZM
- GDTC Buy
- Analyst Count
- IZM 0
- GDTC 1
- Target Price
- IZM N/A
- GDTC $5.00
- AVG Volume (30 Days)
- IZM 29.5K
- GDTC 5.9K
- Earning Date
- IZM 07-25-2025
- GDTC 01-01-0001
- Dividend Yield
- IZM N/A
- GDTC N/A
- EPS Growth
- IZM N/A
- GDTC N/A
- EPS
- IZM N/A
- GDTC N/A
- Revenue
- IZM $180,553,977.00
- GDTC $368,838.00
- Revenue This Year
- IZM N/A
- GDTC $5.37
- Revenue Next Year
- IZM N/A
- GDTC N/A
- P/E Ratio
- IZM N/A
- GDTC N/A
- Revenue Growth
- IZM N/A
- GDTC N/A
- 52 Week Low
- IZM $1.18
- GDTC $1.20
- 52 Week High
- IZM $3.19
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- IZM 56.02
- GDTC 44.67
- Support Level
- IZM $2.50
- GDTC $2.08
- Resistance Level
- IZM $2.74
- GDTC $2.31
- Average True Range (ATR)
- IZM 0.10
- GDTC 0.11
- MACD
- IZM -0.00
- GDTC -0.00
- Stochastic Oscillator
- IZM 57.89
- GDTC 12.18
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.